<- Go Home
Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. Eucrates Biomedical Acquisition Corp. was incorporated in 2020 and is based in New York, New York.
Market Cap
$42.2M
Volume
17.3K
Cash and Equivalents
$18.9K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$10.25
52 Week Low
$9.87
Dividend
N/A
Price / Book Value
-11.36
Price / Earnings
48.36
Price / Tangible Book Value
-11.36
Enterprise Value
$42.3M
Enterprise Value / EBITDA
N/A
Operating Income
N/A
Return on Equity
52.56%
Return on Assets
N/A
Cash and Short Term Investments
$18.9K
Debt
$60.1K
Equity
-$3.7M
Revenue
N/A
Unlevered FCF
N/A
Sector
Capital Markets
Category
N/A